Annual report pursuant to Section 13 and 15(d)

Note 13 - Employee and Director Benefits (Tables)

v3.20.4
Note 13 - Employee and Director Benefits (Tables)
12 Months Ended
Dec. 31, 2020
Notes Tables  
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
   

2019

   

2018

 

Expected price volatility

    40.00

%

    35.39

%

Expected dividend yield

    1.76

%

    1.24

%

Expected term (in years)

    7       6  

Risk-free rate

    1.96

%

    2.90

%

Share-based Payment Arrangement, Option, Activity [Table Text Block]
   

Shares

   

Weighted Average Exercise Price

   

Weighted Average Remaining Contractual Term (years)

   

Aggregate Intrinsic Value

 
                           

(In Thousands)

 

Year Ended December 31, 2020:

                               

Outstanding at beginning of year

    965,248     $ 15.19       4.9     $ 21,911  

Exercised

    (306,300 )     11.38       2.9       8,854  

Forfeited

    (18,000 )     30.79       6.1       171  

Outstanding at end of year

    640,950     $ 18.14       4.6     $ 16,981  
                                 

Exercisable at December 31, 2020:

    182,200     $ 12.86       3.5     $ 4,998  
                                 

Year Ended December 31, 2019:

                               

Outstanding at beginning of year

    1,238,748     $ 13.02       5.2     $ 23,355  

Granted

    35,500       34.06       9.6       129  

Exercised

    (288,800 )     7.56       2.5       8,534  

Forfeited

    (20,200 )     24.88       6.2       259  

Outstanding at end of year

    965,248     $ 15.19       4.9     $ 21,911  
                                 

Exercisable at December 31, 2019:

    278,500     $ 8.28       3.0     $ 8,355  
                                 

Year Ended December 31, 2018:

                               

Outstanding at beginning of year

    1,666,834     $ 10.68       5.5     $ 51,377  

Granted

    42,250       37.21       9.6       -  

Exercised

    (414,336 )     5.73       2.8       10,832  

Forfeited

    (56,000 )     15.40       6.2       912  

Outstanding at end of year

    1,238,748     $ 13.02       5.2     $ 23,355  
                                 

Exercisable at December 31, 2018:

    510,100     $ 7.08       3.5     $ 12,645  
Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]

Range of Exercise Price

   

Shares

   

Weighted Average Exercise Price

   

Weighted Average Remaining Contractual Term (years)

   

Aggregate Intrinsic Value

 
                                   

(In Thousands)

 
$ 5.00 - 6.00       56,000     $ 5.36       2.0     $ 1,956  
  15.00 - 16.00       89,200       15.39       4.1       2,221  
  17.00 - 18.00       26,000       17.16       4.3       602  
  18.00 - 19.00       10,000       18.57       4.5       217  
  38.00 - 39.00       1,000       38.06       6.1       2  
              182,200     $ 12.86       3.5     $ 4,998  
Nonvested Restricted Stock Shares Activity [Table Text Block]
   

Shares

   

Weighted Average Grant Date Fair Value

 

Year Ended December 31, 2020:

               

Non-vested at beginning of year

    71,290     $ 32.24  

Granted

    33,695       33.91  

Vested

    (20,178 )     23.76  

Forfeited

    (500 )     34.09  

Non-vested at end of year

    84,307     $ 34.92  
                 

Year Ended December 31, 2019:

               

Non-vested at beginning of year

    42,576     $ 29.96  

Granted

    36,664       33.60  

Vested

    (5,450 )     20.92  

Forfeited

    (2,500 )     38.17  

Non-vested at end of year

    71,290     $ 32.24  
                 

Year Ended December 31, 2018:

               

Non-vested at beginning of year

    120,676     $ 10.29  

Granted

    16,350       39.84  

Vested

    (93,200 )     6.07  

Forfeited

    (1,250 )     41.21  

Non-vested at end of year

    42,576     $ 29.96